LOGIN
ID
PW
MemberShip
2025-06-16 08:22
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
[Reporter's View] Fostering BD talent requires tech¡¤strateg
Reporter's view |
Whang, byung-woo
[Reporter's View] Biotech policy must be consistent
Reporter's view |
[Reporter's View] Addressing drug shortage, healthcare
Reporter's view |
Lee, Jeong-Hwan
INTERVIEW
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Hemlibra shows long-term efficacy and safety in hemophilia
Long-term prevention of bleeding episodes
"High hopes for reimbursed Ilaris¡¦a new treatment option"
Dr. Soyoung Lee, Professor of Pediatric & Adolescent Medicine at Hallym University Sacred Heart Hospital
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Pharma-distributor 'margin war' heats up again
2
Ruling party proposes bill for free HPV vaccination
3
New ADC drug Padcev seeks reimb again in Korea
4
Latecomer psoriasis drug Bimzelx enters competition in KOR
5
Distributors Association plans "strong response"
6
Denosumab¡¯s reimbursement denials increase due to stricter
7
New RNAi drug 'Rivfloza' gets ODD in KOR
8
Atopic dermatitis drug Ebglyss reimbursed from next month
9
Anti-PD-1 immunotherapy 'Zynyz' gets ODD in KOR
10
Roche¡¯s SMA drug Evrysdi Tab approved in Korea